Overview
Dr. Karsten Suhre joined Weill Cornell Medicine-Qatar (WCM-Q) in March 2011 as Professor of Physiology and Biophysics and Director of the Bioinformatics Core.
From 2006 until joining WCM-Q, Dr. Suhre served as Professor in the Department of Biology at Ludwig-Maximilians-University in Munich (LMU), Germany. During that time, he also served as Group Leader for Metabolomics Research at the Institute for Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Centre for Environmental Health. Before 2006, Dr. Suhre worked at the French National Centre for Scientific Research (CNRS) as a Director of Research.
Dr. Suhre's research interests focus on metabolomics and genetic epidemiology, bioinformatics, functional and structural biology. On these subjects, Dr. Suhre has taught multiple courses, published over seventy articles in peer-reviewed journals, and delivered numerous international presentations.
Prior to joining WCM-Q, Dr. Suhre established the field of genome-wide association study of human metabolism, which is reflected in several high-impact publications in the field of which he is the senior author.
As a faculty member of WCM-Q since March 2011, Dr. Suhre’s now studies how genetic variation in human metabolism interacts with environmental challenges and lifestyle factors in the development of complex diseases, including diabetes, heart and kidney diseases. Knowledge of the genetic basis of metabolic individuality in humans generates many new hypotheses for biomedical and pharmaceutical research, and potentially informs individualized therapy.
He is currently involved in setting up clinical studies in cooperation with different health organizations in Qatar, including diabetes and ovarian cancer, which centrally involve his specific knowledge in the field of metabolomics.
Highlights
- 1
- 2Nature communications · 2024
- 3Nature communications · 2021
Publications
Funding
Active
2 grants- Sub-PIARG01-0420-230007Investigating gut metabolite markers and potential protective probiotic intervention in non-obese, apparently healthy individuals with insulin resistanceQatar National Research Fund · 2024–2027 · via Qatar University
- Sub-PINPRP11C-0115-180010Qatar Diabetes Prevention Program (QDPP)Qatar National Research Fund · 2019–2026 · via Hamad Medical Corporation
Completed grants (9)
- Sub-PIIRGC-07-SI-20-745Footprints of Insulin Sensitivity in Women From Arabic EthnicityQatar National Research Fund · 2021–2024 · via Hamad Medical Corporation
- PISA 203114-01Memorandum of Agreement - Services between WCMC and WCMC-Q campusesWeill Cornell Medical College · 2020–2020Contract
- PISA 183539-02Molecular characterization services on 350 of WCM-Q's serum samples for Dr Suhre's labLeiden University Medical Center · 2018–2020Contract
- MPISMRC 190127-01Analysis of the inflammatory profile in childhood onset diabetesSidra Medical and Research Center · 2018–2019Contract
- MPINPRP 8-061-3-011Rational Metabolic Engineering as a New Tool for Targeted Intervention in Human MetabolismQatar National Research Fund · 2016–2019
- PIICL 182926-01Core services agreement for Bioinformatics Core to provide services to Imperial College LondonImperial College of London · 2018–2019Contract
- PISRA 192004Collaboration Agreement SIDRA and WCMQSidra Medical and Research Center · 2017–2018Contract
- MPIDUA 181891-01Metabolomics Systems Biology InitiativesWeill Cornell Medical College/Qatar · 2017–2018Contract
- KPR37AI051652-13Urine Metabolomics for the Noninvasive Diagnosis of Antibody Mediated Rejection in Kidney AllograftsNational Institute of Allergy and Infectious Diseases · 2016–2018
News mentions
- Human ‘Molecular Map’ Contributes to the Understanding of Disease MechanismsSeptember 10, 2024
Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers.
- Qatar Genome Research Consortium Reports First and Largest Comprehensive Genetic Association Study in Middle EastFebruary 25, 2021
The first and largest genetic association study in the Middle East revealed genetic variations that are specific to the Qatari population, a group of researchers at Qatar Foundation reported Feb. 23 in Nature Communications.